Logo
x

Search

Subscribe Now

J&J

Johnson & Johnson Submits NDA to the US FDA for TAR-200 to Treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer (HR-NMIBC)

Johnson & Johnson Submits NDA to the US FDA for TAR-200 to Treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer (HR...

  • January 17, 2025
Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

  • March 29, 2023
Top 20 Immunology Companies Based on 2021 Immunology Segment Total Revenue

Top 20 Immunology Companies Based on 2021 Immunology Segment Total Revenue

  • August 11, 2022
J&J Pauses Dosing in COVID-19 Vaccine Studies Due to Unexplained Illness

J&J Pauses Dosing in COVID-19 Vaccine Studies Due to Unexplained Illness

  • October 14, 2020
J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

  • September 24, 2020
Johnson & Johnson Vision Launches TECNIS Eyhance Monofocal Intraocular Lens for Post Cataract Surgery Patients in India

Johnson & Johnson Vision Launches TECNIS Eyhance Monofocal Intraocular Lens for Post Cataract Surgery Patients in India

  • October 31, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.